Objective: To examine the purchasing and supply patterns of new psychoactive substance (NPS) consumers in Australia.
| INTRODUCTION
Over the past decade, the number and range of substances collectively referred to as "new psychoactive substances" (NPS) has increased dramatically (European Monitoring Centre for Drugs and Drug Addiction, 2016b) . NPS are defined by the European Monitoring Centre for Drugs and Drug Addiction as substances that do not fall under international drug controls but which may pose a public health threat (European Monitoring Centre for Drugs and Drug Addiction, 2016b) . However, there is no universally accepted way of determining whether individual substances are included within the NPS definition. "Older new" drugs, such as those currently controlled by international legislation but not previously well established in the recreational drug-using scene (e.g., dimethyltryptamine; DMT), are also often included as NPS.
In 2015, the European Union were monitoring over 560 NPS, of which 70% were detected in the past 5 years (European Monitoring Centre for Drugs and Drug Addiction, 2016b) . The rapid growth of the NPS market has been facilitated by a number of factors, one of which is the expansion of online marketplaces (European Monitoring Centre for Drugs and Drug Addiction, 2016a, 2016c) . The first online drug transaction is reported to have occurred in 1971 (Buxton & Bingham, 2015) , and over the past decade, there has been an increasing awareness of, and interest in, surface Web markets and cryptomarkets (Walsh, 2011) . Surface Web markets are accessible via typical search engines (e.g., Google and Yahoo) and cryptomarkets (also known as dark net markets) exist in a "hidden" part of the Internet not accessible through standard Web browsers. Cryptomarkets host multiple sellers or vendors and have been facilitated by the development of encryption, digital currencies, and anonymous browsing (Barratt & Aldridge, 2016a; Mounteney, Griffiths, & Vandam, 2016; . The expansion of these online drug markets have provided new opportunities for the supply and purchase of drugs, with Internet sales of NPS now an international phenomenon and many online stores advertising worldwide delivery (European Monitoring Centre for Drugs and Drug Addiction, 2011).
As surface Web and cryptomarkets have grown, so too has the monitoring of such marketplaces. In 2011 -2012 , Bruno, Poesiat, and Matthews (2013 identified 43 unique surface Web markets that were selling stimulant and psychedelic NPS to Australia, and there are currently over 20 cryptomarkets selling illicit drugs, including NPS (although not all vendors operating on these marketplaces sell to Australia; Barratt & Aldridge, 2016b; . In December 2015, NPS were found to be the sixth most commonly sold substances on AlphaBay and Nucleus (the two largest cryptomarkets at that time); 2C-x, DMT, and NBOMe were the most commonly sold substances within this category . Although the online availability of NPS largely corresponds with the main NPS used in Australia (Sindicich, Stafford, & Breen, 2016) , there is little evidence regarding the relative importance of online markets as a source of supply for NPS consumers. Indeed, despite being readily available online, and despite the widely held perception that most NPS are purchased online, it appears that most Australian consumers do not source NPS in this manner. That is, despite findings that NPS users are "more likely" to purchase drugs online than other drug users (Burns et al., 2014; , for the most part, they appear to obtain these substances from "in-person" sources such as friends and dealers (Burns et al., 2014; European Commission, 2014; Stephenson & Richardson, 2014) , although this can vary across studies (e.g., see Global Drug Survey, 2016; O'Brien, Chatwin, Jenkins, & Measham, 2015; Soussan & Kjellgren, 2016) .
However, despite potential heterogeneity in the forms of NPS used, and in the primary sources for each NPS, many of these studies combine NPS into a single category for analysis. Studies examining individual types or categories of NPS suggest that differences may exist across consumers; for example, friends have been found to be the most common source for obtaining DMT (Australia; Cakic, Potkonyak, & Marshall, 2010) and mephedrone (Ireland; McElrath & O'Neill, 2011) , whilst other studies have found that the Internet was the most common source for obtaining plant-derived NPS (Sweden; Björnstad, Hultén, Beck, & Helander, 2009 ) and NBOMe (international; Lawn, Barratt, Williams, Horne, & Winstock, 2014) . In regard to synthetic cannabinoids, retail outlets have been found to be a common source for obtaining these substances (Barratt, Cakic, & Lenton, 2013; Gunderson, Haughey, Ait-Daoud, Joshi, & Hart, 2014) . At present, it is unclear if such findings represent genuine differences across NPS, or if they are the result of different methodologies, geographic differences, and/or other study artefacts.
In addition to the direct purchasing of NPS for personal use, the Internet could play a significant role in social supply (i.e., the noncommercial or non-profit-making distribution of drugs to nonstrangers; Hough et al., 2003) , where one friend within a social group may purchase NPS online to provide to others within the group, either for free, at cost price, or for profit. There are some anecdotal reports of this taking place (Stephenson & Richardson, 2014) ; however, the overall extent to which this is happening remains unknown. Given that social supply is common among illicit drug users (Belackova & Vaccaro, 2013; Bernard & Werse, 2013; Fowler, Kinner, & Krenske, 2007; Lenton, Grigg, Scott, Barratt, & Eleftheriadis, 2015) , it seems likely that this practice would extend to NPS and online marketplaces. Furthermore, little is known about the extent to which people are obtaining NPS from online sources for the purposes of dealing for cash profit. This is of particular interest given that online drug marketplaces have reconfigured relationships among suppliers, intermediaries, and buyers, with some evidence showing that individuals, couples, and very loose networks are becoming key criminal actors in Internet-facilitated drug trafficking (Lavorga, 2016) .
In this paper, we examined the supply and purchasing patterns of a sample of NPS consumers in Australia, with an emphasis on exploring online purchasing. Specifically, we aimed to 1. Determine whether there were different purchasing and supply patterns across consumers of the most commonly used NPS, specifically DMT, 2C-x, NBOMe, and synthetic cannabinoids; and 2. Examine whether purchasing and supply patterns differed across NPS consumers who nominated "online" as their main NPS source compared to those who nominated an alternative main source. 2.2 | Participants and procedure EDRS survey participants are a self-selected sample of RPU recruited through street-press advertisements, online forums, and peer referral.
Eligibility criteria were at least monthly use of ecstasy or other psychostimulants in the preceding 6 months, 16 years of age or older, and residence in the city of interview for at least 12 months prior to the interview. Face-to-face structured interviews of approximately 1-hour duration were conducted by trained interviewers at a negotiated time and location, and participants were reimbursed AUD40 for their time and out-of-pocket expenses.
In 2016, 795 participants were recruited and interviewed for the EDRS. Analysis is based on a subset of participants who reported past-year use of NPS (n = 296; Table 1 ).
| Measures relevant to the current study
In addition to demographic questions (i.e., age, gender, sexual orientation, employment, and educational status), participants were asked about their lifetime and past 6-month use of licit and illicit substances.
Participants who had used any NPS in the "past year" were asked to nominate the NPS used most often in that time frame and were then asked a series of questions in relation to use of that particular substance, including how they obtained the substance (bought it or given for free or exchange; multiple responses allowed); typical and largest transaction sizes; the main source from whom they obtained this substance (friend or dealer or workmate or acquaintance or relative or online or other) and whether they obtained any other drugs from this source (including both "traditional" illicit drugs and other Note. Significant findings bolded. Adjusted residuals only reported when p < .05. DMT = dimethyltryptamine; IQR = interquartile ranges; NPS = new psychoactive substances.
a DMT (n = 104); 2C-x (n = 59); NBOMe (n = 27); synthetic cannabis (n = 23); herbal highs (n = 18); MXE (n = 16); methylone (n = 9); mephedrone (n = 5); PMA (n = 7); Salvia divinorum (n = 5); etizolam (n = 5); mescaline (n = 4); 5-Meo-DMT (n = 2); LSA (n = 1); datura (n = 1); 3-MeO-PCP (n = 1); 5-MAPB (n = 1); ayahuasca (n = 1); changa (n = 1); kava (n = 1); 5-Meo-MIPT (n = 1); NBOH (n = 1); phenibut (n = 1); unknown (n = 2).
b Multiple responses allowed, hence, sum of percentages may exceed 100%. Workmates (1%); relatives (0.7%); and home-made/grown (1.7%).
d Excluded from subsequent analysis, due to small numbers (n < 10).
e Cryptomarkets (n = 23) and surface Web marketplaces (n = 3); association remains significant even when surface Web marketplaces are excluded from analysis.
f Among those who had supplied NPS to others in the past year. NPS); whether they had supplied NPS to others in the past 12 months; who they supplied NPS to; and the method of supply (gave away for free or shared or provided at cost price or provided for cash profit or exchanged; multiple responses allowed).
| Statistical analysis
To address the first aim, we compared purchasing and supply patterns across the most commonly used NPS, namely, DMT (n = 104), the 2C-family substances (2C-x; n = 59), NBOMe (n = 27), and synthetic cannabinoids (n = 22). Between-group comparisons of categorical variables were analysed using chi-squared tests (χ 2 ), and adjusted residuals were used to analyse which cell differences contributed to the overall χ 2 results. An adjusted residual score of greater than 2.0 or below −2.0 indicated that the cells differed significantly.
To address the second research aim, we divided the sample into 2 groups on the basis of whether participants nominated "online" as their main source for obtaining their most frequently used NPS in the past year or whether they nominated a "non online" source. Between-group comparisons of categorical variables were analysed using risk ratios (RR) with 95% confidence intervals reported. 3 | RESULTS
| Sample characteristics
The sample (n = 296) had a median age of 21 years (interquartile range 19-24); 71% of participants were male, 97% were of English speaking background, 45% were tertiary qualified, 73% were employed in some capacity, 36% were students, 12% were unemployed, and 2% were currently in drug treatment. Almost all (98%) participants reported recent (past 6 months) use of ecstasy, 42% reported recent methamphetamine use, 51% reported recent cocaine use, 66% reported recent lysergic acid diethylamide (LSD) use, and 92% reported recent cannabis use. Forty-six percent of participants reported using ecstasy or related drugs on a weekly or greater basis in the past month. The most commonly used NPS within the preceding 6 months were DMT (38%), 2C-B (24%), synthetic cannabinoids (11%), and NBOMe (10%), although frequency of use for each of these drugs was low (range:
1-3 days).
| Differences in purchasing patterns across NPS consumers
Three-fifths (61%) of all NPS consumers reported that they had purchased NPS in the past year. This was significantly higher among participants who nominated NBOMe as the main NPS used in the past year (89%), compared to those to nominated DMT (53%), 2C-x (61%), and synthetic cannabis (52%) as the main NPS used (p = .007; Table 1 ).
Almost half (46%) of consumers reported being given NPS for free, and a small minority (7%) reported that they had received the substance in exchange for something else (e.g., other drugs), with no differences found across substances.
Most consumers (58%) nominated a friend as their main source for obtaining NPS in the past year. However, when comparisons were made across DMT, 2C-x, NBOMe, and synthetic cannabinoid users, it was found that NBOMe users were more likely to nominate a dealer (30%; p = .045) or online marketplace (22%; p = .010) as their main source, although synthetic cannabinoid users were more likely to nominate a shop (44%; p < .001) as their main source. Over half (57%) of all NPS consumers reported that they had obtained other drugs from their main NPS source, with 2C-x consumers (71%) being more likely to have done so (p = .029). Typical and largest transaction sizes were the same across all four NPS (hence only typical transaction sizes have been presented) and were relatively small for all substances.
| Differences in supply patterns across NPS consumers
Almost half (46%) of all NPS consumers reported that they had supplied NPS to other people in the past 12 months, with NBOMe (63%) and DMT (52%) consumers being more likely to have done so and 2C-x users (22%) being less likely (p = .001; Table 1 ). Among those who had supplied to others, most reported that they had provided NPS to friends (96%), typically sharing them (56%) or giving away them for free (45%). However, NBOMe consumers were less likely to have supplied NPS to friends (82%; p = .022) and to have shared with others (29%; p = .032) and were more likely to have supplied to strangers (29%; p < .001) and acquaintances (24%; p = .003). They were also more likely to have sold NPS for cash profit (29%; p = .051).
| Main source for obtaining NPS: online vs non online
Nine percent of NPS consumers nominated online marketplaces as their main source for obtaining these substances in the past year. This mostly consisted of "cryptomarkets" (n = 23), with a minority nominating "surface Web markets" (n = 3) as their main source.
Participants who nominated an online marketplace as their main source for obtaining NPS had obtained a larger number of drugs from this source (median 5 vs. 2; p < .001) and were subsequently more likely to have obtained other drugs from this source (RR 1.57 95% CI: 1.29-1.92), when compared to participants who nominated an alternative main source (Table 2 ). All participants who nominated an online marketplace as their main NPS source and who had obtained other drugs online reported that they had purchased "traditional" illicit drugs (mainly ecstasy, LSD, benzodiazepines, and cannabis) from this source, and 55% reported that they had obtained another NPS. NPS consumers who nominated online as their main source were also more likely to have supplied NPS to others in the past year (RR 1.57 95% CI:
1.35-2.27) and were more likely to have supplied to strangers (RR 6.05 95% CI: 1.65-22.17) and acquaintances (RR 12.11 95% CI: 3.31-44.34). Furthermore, they were more likely to have sold NPS for cash profit (RR 4.36 95% CI: 2.02-9.43) and to have exchanged it for something else (RR 3.27 95% CI: 1.37-7.80). There were no significant differences in terms of typical NPS transaction sizes for pills, caps, and grams. For "tabs" of blotter paper, the median typical transaction size among participants who nominated online as their main source was 30 tabs compared to one tab for those who nominated an alternative main source (p = .017).
These associations remained significant even when participants who nominated the surface Web as their main source for obtaining NPS were excluded from analyses.
| DISCUSSION
We found significant differences in purchasing and supply patterns across NPS consumers. Overall, friends were nominated as the main source for obtaining these substances; however, analysis of DMT, 2C-x, NBOMe, and synthetic cannabinoids consumers showed that NBOMe users were more likely to nominate a dealer or online marketplace as their main source, although synthetic cannabinoid users were more likely to nominate a shop as their main source. These findings are relatively consistent with previous research Gunderson et al., 2014; Lawn et al., 2014) , as well as with media reports suggesting that synthetic cannabinoids remain readily available via retail outlets (despite being largely prohibited across Australia, e.g., Wordsworth, 2016) .
It is unclear why NBOMe is more likely than DMT, 2C-x, and synthetic cannabinoids to be purchased online; however, consumer preference, availability, and price are likely to all play a role. In relation to consumer preference, a study comparing the subjective experiences of NPS relative to their traditional illicit drug counterparts found that 2C-B and 2C-I were rated less favourably than LSD in terms of pleasurable effects and likelihood of taking again (Matthews et al., 2016 [In Press]) , and a study of dual cannabis and synthetic cannabis users found a strong preference for natural cannabis over synthetic cannabis (Winstock & Barratt, 2013) . In contrast, NBOMe has been found to have a very similar profile of subjective effects when compared to other hallucinogens (i.e., LSD, magic mushrooms, and ketamine; Lawn et al., 2014) . Given that consumers are presented with a smorgasbord of substances (and vendors) when purchasing online, it seems unlikely that they would purchase substances (e.g., 2C-x, synthetic cannabinoids) that are generally considered inferior to established illicit drugs, Note. Significant findings bolded. IQR = interquartile ranges; NPS = new psychoactive substances; RR = risk ratio.
a Cryptomarkets (n = 23) and surface Web marketplaces (n = 3). Associations remain significant even when surface Web marketplaces are excluded from analyses (except for "supplying to relatives," which loses significance).
b Risk ratios (RR) and 95% confidence intervals (95% CI) are reported for chi-square analyses; results of the Mann-Whitney U test (U) are reported for the comparison of medians. c Among those who had supplied NPS to others in the past year; multiple responses allowed, hence, sum of percentages may exceed 100%.
d This association loses significance when "surface Web" marketplaces are excluded from analysis.
with psychonauts (a minority group interested in trying a wide variety of drugs; Ott, 2001 ) being the exception. In contrast, those purchasing from a retail outlet, friend, or dealer are limited by what is available at that time and thus may be more prone to "opportunistic" purchases.
Indeed, a recent study found that availability (i.e., no other drug available at the time) and legality were the most highly endorsed motivations for synthetic cannabinoid use among RPU in Australia (Sutherland et al., In Press) , providing some support for this theory of opportunistic purchasing.
Another factor to consider is price. Cheaper prices is reportedly one of the most common reasons for purchasing drugs online (Barratt, Ferris, & Winstock, 2014; , although it is unclear if this varies across substances, with very few studies explicitly examining this topic. Interestingly, one of the only published studies to compare the mean prices of drugs bought online versus offline found that online prices were "higher" than offline prices for ecstasy tablets, amphetamine powders, cocaine powders, LSD, 4-FA powders, and 5/6-APB powders, with no significant differences in prices for 2C-B tablets, 2C-B powders, and methoxetamine powders In regards to the provision of NPS, we found that almost half of all NPS consumers had supplied these substances to others in the preceding 12 months, with NBOMe and DMT consumers being significantly more likely to have done so. Social supply was by far the most common form of supply, with most participants reporting that they had supplied to friends for no cash profit (i.e., shared, given away for free, or provided at cost price). Indeed, mutual supply networks appear to be common among NPS consumers, with many individuals both sourcing from and supplying to friends. This is consistent with previous research
showing that individuals within friendship groups source drugs from, and concurrently supply to, group members to ensure a consistent supply of quality product and to minimise risks of health harms and criminal justice consequences (Bright & Sutherland, Under Review; Lenton et al., 2015; Nicholas, 2008) .
Although social supply was the most common form of supply reported by participants, NBOMe consumers, and those who nominated online markets as their main NPS source, were more likely to report supplying NPS to strangers and acquaintances and for cash profit. It is unclear if this represents a "drift" into dealing for cash profit (whereby users gradually become dealers; Taylor & Potter, 2013) , or if it is representative of existing dealers taking advantage of new business opportunities. As mentioned previously, "cheaper prices" is one of the main reasons for sourcing drugs online, particularly amongst Australian consumers , and it seems feasible that the potential for high profit margins could attract existing dealers and also facilitate a drift into dealing for cash profit among those who were initially purchasing for personal use and/or social supply (e.g., "My time as a scumbag NBOMe dealer," 2015). Indeed, although the typical transaction size for
NBOMe was relatively small in the current study (median of three tabs), there were some individuals buying in much higher quantities.
Furthermore, it is unknown if those supplying NBOMe to others (for profit or otherwise) are supplying it at face value or as an alternative substance (i.e., LSD). When deposited on blotter paper, LSD and
NBOMe are virtually identical in appearance and, given the health risks associated with unwittingly ingesting NBOMe (e.g., increased risk of overdose), concerns have been raised about the possibility of NBOMe being sold as LSD (Caldicott, Bright, & Barratt, 2013; Isbister, Poklis, Poklis, & Grice, 2015) . This practice has been verified in some 
| Limitations
Our analysis is reliant upon self-report data from participants that may be subject to bias. Although evidence points to sufficient validity and reliability of self-report in studies assessing illicit drug use (Darke, 1998) , it is possible that participants may have (a) under-reported purchasing and supply patterns and (b) incorrectly identified the NPS being consumed (i.e., it may have been sold to them as one thing but have been something else). The latter is particularly pertinent in relation to LSD and NBOMe, and future studies should corroborate selfreport with chemical analysis. Additionally, the EDRS sample is not representative of all RPU consumers in Australia, although an assessment of the EDRS data in NSW did find that it had high generalisability to population estimates (Topp, Barker, & Degenhardt, 2004) . Similarly, the EDRS sample is not representative of all NPS users, with supply and purchasing patterns likely to be quite different among certain subpopulations (e.g., NPS consumers who are homeless or incarcerated).
In regard to supplying NPS for "cash profit," it is unknown how much profit was actually made, and it is possible that this included "minimally commercial supply" (Coomber & Moyle, 2014) , whereby small financial gain is made but is not the primary driver of drug supply. Furthermore, our findings relate to the "main" NPS used in the past year and the main source for obtaining this substance; it is important to note that some participants had used multiple NPS in the past year and would have likely obtained these substances through multiple sources.
Finally, some of our findings are based on relatively small sample sizes, meaning that caution must be exercised when interpreting null results.
| CONCLUSION
The recent proliferation of NPS, combined with their global distribution through the Internet and other sources, raises important questions about how consumers and dealers engage with the market for these drugs. Our study found that most NPS consumers continue to source these substances from in-person sources such as friends and dealers, although this varied across substances. Social supply and mutual supply networks were common, with many participants both sourcing from and supplying to friends. 
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